EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Efficacy and Safety of Leadless Pacemaker Implantation in Octogenarians

Daniel Hofer, François Regoli, Ardan M Saguner, Giulio Conte, Julius Jelisejevas, Maria Luce Caputo, Vera Graup, Lorenzo Grazioli Gauthier, Alessio Gasperetti, Jan Steffel, Angelo Auricchio, Alexander Breitenstein

Cardiology · 2023

DOI: 10.1159/000532075 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cardiology, 2023. Verfasst von Daniel Hofer und 11 weiteren Autor:innen. Beteiligte Einrichtung: Electrophysiology, Department of Cardiology, University Hospital Zurich, Zurich, Switzerland. Hauptthemen laut MEDLINE: Pacemaker, Artificial, Atrial Fibrillation. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 21 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Long-term complication rates in standard transvenous pacemakers are reported around 4–12% with a higher incidence in the elderly population. We report our experience in octogenarians undergoing leadless pacemaker implantation in two large-volume centers in Switzerland.

Methods

Consecutive patients undergoing leadless pacemaker implantation at two Swiss large volume centers (University Hospital Zurich, Zurich and Cardiocentro Ticino Institute, Lugano) between October 2015 and March 2020 were included in this retrospective analysis. Demographic information, clinical data, and procedural characteristics were recorded at the day of implantation and during follow-up.

Results

Two hundred and twenty patients (mean age 80.6 ± 7.7 years, male 66%) were included. The main indication for pacemaker implantation was slow ventricular rate atrial fibrillation (111 of 220 patients, 50.4%). Out of the 220 patients, 124 (56.3%) were ≥80 years. Overall successful implantation rate was 98.6%. In the octogenarian population, the median procedure time (45 ± 20.2 min vs. 40 ± 19.6 min, p = 0.03) and radiation duration (6.1 ± 8.2 min vs. 5.0 ± 7.2 min, p = 0.03) were longer compared to patients <80 years. Major complications (2.7%, n = 6) and device measurements during follow-up were similar between patients ≥80 and <80 years.

Conclusion

Implantation of a leadless pacemaker device in octogenarians is safe and effective with a similarly low complication rate compared to non-octogenarians.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pacemaker, ArtificialAtrial FibrillationAged, 80 and overHumansMaleAgedOctogenariansRetrospective StudiesTreatment OutcomeVentricular FibrillationEquipment Design

Stichwörter der Autor:innen

Complication ratesEfficacyElderly populationLeadless pacing

Autor:innen und Institutionen

  • Electrophysiology, Department of Cardiology, University Hospital Zurich, Zurich, Switzerland.
  • Cardiocentro Ticino Institute, Lugano, Switzerland.
  • Cardiology, San Giovanni Hospital, Bellinzona, Switzerland.
  • Department of Anaesthesiology, University Hospital Zurich, Zurich, Switzerland.

Zitieren

APA

Hofer, D., Regoli, F., Saguner, A. M., Conte, G., Jelisejevas, J., Luce Caputo, M., Graup, V., Grazioli Gauthier, L., Gasperetti, A., Steffel, J., Auricchio, A., & Breitenstein, A. (2023). Efficacy and Safety of Leadless Pacemaker Implantation in Octogenarians. Cardiology. https://doi.org/10.1159/000532075

Vancouver

Hofer D, Regoli F, Saguner AM, Conte G, Jelisejevas J, Luce Caputo M, et al. Efficacy and Safety of Leadless Pacemaker Implantation in Octogenarians. Cardiology. 2023. doi:10.1159/000532075

BibTeX
@article{Hofer2023,
  author = {Hofer, Daniel and Regoli, François and Saguner, Ardan M and Conte, Giulio and Jelisejevas, Julius and Luce Caputo, Maria and Graup, Vera and Grazioli Gauthier, Lorenzo and Gasperetti, Alessio and Steffel, Jan and Auricchio, Angelo and Breitenstein, Alexander},
  title = {Efficacy and Safety of Leadless Pacemaker Implantation in Octogenarians},
  journal = {Cardiology},
  year = {2023},
  doi = {10.1159/000532075}
}
Kostenlos starten →